Exploring the Interplay Between Inflammatory and Metabolic Markers in Depression Treatment Outcomes: A Focus on Interleukin-6 and Ghrelin
Aims: This study aimed to elucidate the modulating effects of serum ghrelin on the relationships between interleukin-6 (IL-6) and antidepressant treatment outcomes, particularly focusing on 12-week remission and 24-month relapse in patients with depressive disorders.
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-06-01
|
| Series: | BJPsych Open |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425101622/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|